B · Normal
[Qianhong Pharmaceutical: QHRD106 injection project is in the phase IIb clinical closing stage] On October 27, Qianhong Pharmaceutical stated at the performance briefing meeting that the company's QHRD106 injection (acute ischemic stroke) project is currently in the phase IIb clinical closing stage. After completing the communication with the national CDE, it will promptly advance the phase III clinical and marketing application related work.
Comments